235 related articles for article (PubMed ID: 32364076)
1. Immunotherapy: A Potential Approach to Targeting Cancer Stem Cells.
Wang W; Bai L; Xu D; Li W; Cui J
Curr Cancer Drug Targets; 2021; 21(2):117-131. PubMed ID: 32364076
[TBL] [Abstract][Full Text] [Related]
2. Challenges and opportunities for cancer stem cell-targeted immunotherapies include immune checkpoint inhibitor, cancer stem cell-dendritic cell vaccine, chimeric antigen receptor immune cells, and modified exosomes.
Alqarni A; Jasim SA; Altalbawy FMA; Kaur H; Kaur I; Rodriguez-Benites C; Deorari M; Alwaily ER; Al-Ani AM; Redhee AH
J Biochem Mol Toxicol; 2024 Jun; 38(6):e23719. PubMed ID: 38764138
[TBL] [Abstract][Full Text] [Related]
3. Gastrointestinal cancer stem cells as targets for innovative immunotherapy.
Chivu-Economescu M; Necula LG; Matei L; Dragu DL; Neagu AI; Alexiu I; Bleotu C; Diaconu CC
World J Gastroenterol; 2020 Apr; 26(14):1580-1593. PubMed ID: 32327907
[TBL] [Abstract][Full Text] [Related]
4. Targeted immunotherapy to cancer stem cells: A novel strategy of anticancer immunotherapy.
Yi SY; Wei MZ; Zhao L
Crit Rev Oncol Hematol; 2024 Apr; 196():104313. PubMed ID: 38428702
[TBL] [Abstract][Full Text] [Related]
5. Immunologic Targeting of Cancer Stem Cells.
Zhang J; Li Q; Chang AE
Surg Oncol Clin N Am; 2019 Jul; 28(3):431-445. PubMed ID: 31079798
[TBL] [Abstract][Full Text] [Related]
6. Immunotherapy for targeting cancer stem cells in hepatocellular carcinoma.
Dai X; Guo Y; Hu Y; Bao X; Zhu X; Fu Q; Zhang H; Tong Z; Liu L; Zheng Y; Zhao P; Fang W
Theranostics; 2021; 11(7):3489-3501. PubMed ID: 33537099
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNAs: Emerging regulators for chemo/immunotherapy resistance in cancer stem cells.
Shen C; Yang C; Xia B; You M
Cancer Lett; 2021 Mar; 500():244-252. PubMed ID: 33242560
[TBL] [Abstract][Full Text] [Related]
8. [Identification of cancer-stem cell antigens and development of CTL-mediated cancer immunotherapy].
Miyamoto S; Kanaseki T; Hirohashi Y; Tsukahara T; Kikuchi Y; Sato N; Torigoe T
Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(1):40-47. PubMed ID: 28539553
[TBL] [Abstract][Full Text] [Related]
9. RNA N
Zhang Z; Zhang C; Luo Y; Zhang G; Wu P; Sun N; He J
Clin Transl Med; 2021 Sep; 11(9):e525. PubMed ID: 34586737
[TBL] [Abstract][Full Text] [Related]
10. Selectively targeting cancer stem cells: Current and novel therapeutic strategies and approaches in the effective eradication of cancer.
Esmaeili SA; Sahranavard S; Salehi A; Bagheri V
IUBMB Life; 2021 Aug; 73(8):1045-1059. PubMed ID: 34184810
[TBL] [Abstract][Full Text] [Related]
11. Integrin β4-Targeted Cancer Immunotherapies Inhibit Tumor Growth and Decrease Metastasis.
Ruan S; Lin M; Zhu Y; Lum L; Thakur A; Jin R; Shao W; Zhang Y; Hu Y; Huang S; Hurt EM; Chang AE; Wicha MS; Li Q
Cancer Res; 2020 Feb; 80(4):771-783. PubMed ID: 31843981
[TBL] [Abstract][Full Text] [Related]
12. A New Approach for Cancer Immunotherapy Based on the Cancer Stem Cell Antigens Properties.
Mahmoodi S; Nezafat N; Negahdaripour M; Ghasemi Y
Curr Mol Med; 2019; 19(1):2-11. PubMed ID: 30714514
[TBL] [Abstract][Full Text] [Related]
13. Cancer stem cell antigens as targets for new combined anti-cancer therapies.
Quaglino E; Cavallo F; Conti L
Int J Biochem Cell Biol; 2020 Dec; 129():105861. PubMed ID: 33031926
[TBL] [Abstract][Full Text] [Related]
14. Cancer stem cell immunology and immunotherapy: Harnessing the immune system against cancer's source.
Ruiu R; Tarone L; Rolih V; Barutello G; Bolli E; Riccardo F; Cavallo F; Conti L
Prog Mol Biol Transl Sci; 2019; 164():119-188. PubMed ID: 31383404
[TBL] [Abstract][Full Text] [Related]
15. Nanomicelle protects the immune activation effects of Paclitaxel and sensitizes tumors to anti-PD-1 Immunotherapy.
Yang Q; Shi G; Chen X; Lin Y; Cheng L; Jiang Q; Yan X; Jiang M; Li Y; Zhang H; Wang H; Wang Y; Wang Q; Zhang Y; Liu Y; Su X; Dai L; Tang M; Li J; Zhang L; Qian Z; Yu D; Deng H
Theranostics; 2020; 10(18):8382-8399. PubMed ID: 32724476
[TBL] [Abstract][Full Text] [Related]
16. [Immunotherapy targeting cancer stem cells].
Kawakami Y; Matsushita M; Ueda R; Tsukamoto N; Ohta S
Nihon Rinsho; 2012 Dec; 70(12):2142-6. PubMed ID: 23259387
[TBL] [Abstract][Full Text] [Related]
17. Cancer stem cells: Regulation programs, immunological properties and immunotherapy.
Zhang D; Tang DG; Rycaj K
Semin Cancer Biol; 2018 Oct; 52(Pt 2):94-106. PubMed ID: 29752993
[TBL] [Abstract][Full Text] [Related]
18. Frontiers in cancer immunotherapy-a symposium report.
Cable J; Greenbaum B; Pe'er D; Bollard CM; Bruni S; Griffin ME; Allison JP; Wu CJ; Subudhi SK; Mardis ER; Brentjens R; Sosman JA; Cemerski S; Zavitsanou AM; Proia T; Egeblad M; Nolan G; Goswami S; Spranger S; Mackall CL
Ann N Y Acad Sci; 2021 Apr; 1489(1):30-47. PubMed ID: 33184911
[TBL] [Abstract][Full Text] [Related]
19. Netrin-1 blockade inhibits tumor associated Myeloid-derived suppressor cells, cancer stemness and alleviates resistance to chemotherapy and immune checkpoint inhibitor.
Ducarouge B; Redavid AR; Victoor C; Chira R; Fonseca A; Hervieu M; Bergé R; Lengrand J; Vieugué P; Neves D; Goddard I; Richaud M; Laval PA; Rama N; Goldschneider D; Paradisi A; Gourdin N; Chabaud S; Treilleux I; Gadot N; Ray-Coquard I; Depil S; Decaudin D; Némati F; Marangoni E; Mery-Lamarche E; Génestie C; Tabone-Eglinger S; Devouassoux-Shisheboran M; Moore KJ; Gibert B; Mehlen P; Bernet A
Cell Death Differ; 2023 Oct; 30(10):2201-2212. PubMed ID: 37633969
[TBL] [Abstract][Full Text] [Related]
20. Tumor Plasticity and Resistance to Immunotherapy.
Horn LA; Fousek K; Palena C
Trends Cancer; 2020 May; 6(5):432-441. PubMed ID: 32348738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
